These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 2663511)

  • 1. Growth hormone therapy and leukaemia.
    Stahnke N; Zeisel HJ
    Eur J Pediatr; 1989 Jun; 148(7):591-6. PubMed ID: 2663511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leukemia in growth-hormone-treated patients: an update, 1992.
    Stahnke N
    Horm Res; 1992; 38 Suppl 1():56-62. PubMed ID: 1295814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Growth hormone therapy and leukemia].
    Boose AR; Pieters R; Delemarre-van de Waal HA; Veerman AJ
    Tijdschr Kindergeneeskd; 1992 Feb; 60(1):1-6. PubMed ID: 1557776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adverse events during growth hormone therapy.
    Cowell CT; Dietsch S
    J Pediatr Endocrinol Metab; 1995; 8(4):243-52. PubMed ID: 8821900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Wilms tumour in a patient with growth hormone replacement therapy.
    Momoi T; Yamanaka C; Yorifuji T; Sasaki H; Kaji M; Akiyama Y; Inomata Y; Tanaka K; Mikawa H
    Eur J Pediatr; 1989 Dec; 149(3):159-61. PubMed ID: 2558888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumour occurrence and recurrence.
    Ogilvy-Stuart AL; Shalet SM
    Horm Res; 1992; 38 Suppl 1():50-5. PubMed ID: 1295813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does growth hormone cause relapse of brain tumours?
    Clayton PE; Shalet SM; Gattamaneni HR; Price DA
    Lancet; 1987 Mar; 1(8535):711-3. PubMed ID: 2882131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leukemia and other malignancies among GH users.
    Watanabe S; Mizuno S; Oshima LH; Tsunematsu Y; Fujimoto J; Komiyama A
    J Pediatr Endocrinol; 1993; 6(1):99-108. PubMed ID: 8374697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of somatotropic deficiency with biosynthetic growth hormone].
    Spagnoli A; Bernardini S; Galasso C; Vaccaro F; Manca Bitti ML; Scirè G; Cianfarani S; Spadoni GL
    Pediatr Med Chir; 1989; 11(4):413-8. PubMed ID: 2694106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leukaemia in patients treated with growth hormone.
    Lancet; 1988 May; 1(8595):1159-60. PubMed ID: 2896972
    [No Abstract]   [Full Text] [Related]  

  • 11. Safety of human growth hormone therapy: current topics.
    Allen DB
    J Pediatr; 1996 May; 128(5 Pt 2):S8-13. PubMed ID: 8627474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prevalence of severe growth hormone deficiency in adults who received growth hormone replacement in childhood [see comment].
    Nicolson A; Toogood AA; Rahim A; Shalet SM
    Clin Endocrinol (Oxf); 1996 Mar; 44(3):311-6. PubMed ID: 8729528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The growth hormone cascade: progress and long-term results of growth hormone treatment in growth hormone deficiency.
    Grumbach MM; Bin-Abbas BS; Kaplan SL
    Horm Res; 1998; 49 Suppl 2():41-57. PubMed ID: 9730672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Short stature, Fanconi's anaemia, and risk of leukaemia after growth hormone therapy.
    Butturini A; Bernasconi S; Izzi G; Gertner JM; Gale RP
    Lancet; 1994 Jun; 343(8912):1576. PubMed ID: 7911903
    [No Abstract]   [Full Text] [Related]  

  • 15. Long term growth hormone (GH)-releasing hormone and biosynthetic GH therapy in GH-deficient children: comparison of therapeutic effectiveness.
    Bozzola M; Biscaldi I; Cisternino M; Severi F; Balsamo A; Cacciari E; Pellini C; Chiumello G; Spadoni GL; Boscherini B
    J Endocrinol Invest; 1990 Mar; 13(3):235-9. PubMed ID: 2195098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors for leukemia occurrence among growth hormone users.
    Watanabe S; Yamaguchi N; Tsunematsu Y; Komiyama A
    Jpn J Cancer Res; 1989 Sep; 80(9):822-5. PubMed ID: 2513298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mortality in Canadian children with growth hormone (GH) deficiency receiving GH therapy 1967-1992. The Canadian Growth Hormone Advisory Committee.
    Taback SP; Dean HJ
    J Clin Endocrinol Metab; 1996 May; 81(5):1693-6. PubMed ID: 8626817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of radiation-induced growth hormone deficiency with growth hormone-releasing hormone.
    Ogilvy-Stuart AL; Stirling HF; Kelnar CJ; Savage MO; Dunger DB; Buckler JM; Shalet SM
    Clin Endocrinol (Oxf); 1997 May; 46(5):571-8. PubMed ID: 9231053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent status in the occurrence of leukemia in growth hormone-treated patients in Japan. GH Treatment Study Committee of the Foundation for Growth Science, Japan.
    Nishi Y; Tanaka T; Takano K; Fujieda K; Igarashi Y; Hanew K; Hirano T; Yokoya S; Tachibana K; Saito T; Watanabe S
    J Clin Endocrinol Metab; 1999 Jun; 84(6):1961-5. PubMed ID: 10372694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute lymphoblastic leukemia in a patient with pituitary dwarfism under treatment with growth hormone.
    Hara T; Komiyama A; Ono H; Akabane T
    Acta Paediatr Jpn; 1989 Feb; 31(1):73-7. PubMed ID: 2504031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.